These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5785067)

  • 21. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
    Terlikowski S; Nowak HF
    Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of a potent antitumor agent from a Tahitian sea anemone and methods of administration. Studies with Ehrlich ascites tumor in mice.
    Norton TR; Kashiwagi M
    J Pharm Sci; 1972 Nov; 61(11):1814-7. PubMed ID: 4405724
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
    Nagatsu M; Richart RM; Lambert A
    Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of treatment using a streptococcal preparation (PC-B-45) and mitomycin-C on transplanted mouse tumor.
    Kaibara N; Ikeda T; Hattori T; Inokuchi K
    Gan; 1972 Jun; 63(3):387-90. PubMed ID: 5072838
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
    Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
    Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
    Ivanitskii LP; Makukho LV
    Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of Antitumor Activity of Sodium Phenylbutyrate, Histon Deacetylase Inhibitor, on Ehrlich Carcinoma Model.
    Fadeev NP; Kharisov RI; Kovan'ko EG; Pustovalov YI
    Bull Exp Biol Med; 2015 Sep; 159(5):652-4. PubMed ID: 26468021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo effect of adenosine 3',5'-monophosphate on Ehrlich ascites tumour cells.
    Seller MJ; Benson PF
    Arch Dis Child; 1973 Apr; 48(4):326. PubMed ID: 4350301
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
    Terlikowski S; Sulkowska M; Nowak HF
    J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of detergents on the growth of Ehrlich ascites carcinomas].
    Hanson H; Bohley P
    Z Krebsforsch; 1968; 71(1):51-8. PubMed ID: 4233396
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor.
    Dano K
    Cancer Chemother Rep; 1971 Apr; 55(2):133-41. PubMed ID: 5118683
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. XI. Experimental antineoplastic activity of N-diazoacetyl-D,L-phenylalanine ethyl ester and of N-diazoacetyl-D,L-phenylalanine hydrazide].
    Baldini L; Brambilla G; Cavanna M
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1672-5. PubMed ID: 5982441
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. X. Experimental antineoplastic activity of N-diazoacetyl-D,L-alanine ethyl ester and of N-diazoacetyl-D,L-alanine hydrazide].
    Baldini L; Brambilla G
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1669-72. PubMed ID: 5982440
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 38. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
    Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
    Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
    Watanabe T
    Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.